Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2002096935A3 Long lasting fusion peptide inhibitors for hiv infection
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002066016A3 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002048139A3 Oxazolidinone photoaffinity probes
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187267 Novel 1,2,3,4-tetrahydroisoquinoline, their preparation method and their use as fungicides
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187261 Purine derivatives, process for their preparation and use thereof
10/02/2003US20030187259 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187073 Disinfectant agent
10/02/2003US20030187067 Achilles tendon
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187028 Synergistic mixtures; side effect reduction
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187016 Viricides; anticancer agents
10/02/2003US20030187008 Quinolonecarboxylic acid derivative
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186999 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186957 Methods of treatment and formulations of cephalosporin
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186937 Produced from fermenting suspension of non-pathogenic saprophytic filamentous fungus; for use in food products to improve structure, texture, and stability; for prevention or treatment of immune disorders, tumors or microbial infections
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186900 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
10/02/2003US20030186897 Derivatives of branched-chain lipophilic molecules and uses thereof
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186890 Amphipathic linear peptides and formulations containing said peptides
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186874 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186848 Recombinant iron uptake proteins
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186307 Propagating and replicating procine circoviruses (PCV) for use in vaccine development and as diagnostic aides detecting viral infection in swine; animal husbandry
10/02/2003US20030186283 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186224 CD4+ T-lymphocyte-specific hepatitis C virus-epitopes
10/02/2003US20030185918 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
10/02/2003US20030185912 Anti-microbial compositions and methods of using same
10/02/2003US20030185900 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar (C12H22O11), and water.
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185869 Having lysozyme adsorbed onto or associated with the surface of an active agent
10/02/2003US20030185850 Protective peptides neurotoxin of C. botulinum
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185833 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185793 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
10/02/2003US20030185788 Guanidinium moieties that are either contiguous or spaced along a polymeric backbone, but are sufficiently removed from the backbone via tethers, to allow their interaction with a cell or tissue surface
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003CA2780743A1 Substituted tetracycline compounds
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480284A1 Bioactive hexane fraction from vetiveria zizanioides
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479898A1 Novel .alpha.-amino-n-(diaminophosphinyl)lactam derivatives
10/02/2003CA2479897A1 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479288A1 Process for producing cytotoxic lymphocyte
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 1798